Oh DY, He AR, Qin S, Chen LT, et al. Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study. J Hepatol 2025 May 15:S0168-8278(25)02201-9. doi: 10.1016/j.jhep.2025.
PMID: 40381735